...CONTACT: Erich E. Wanker, Max Delbrück Center for Molecular Medicine Berlin-Buch, Berlin, Germany email: ewanker@mdc-berlin.de Claire Quang Max Delbrueck Center for Molecular Medicine Berlin-Buch Amyloid...

...CONTACT: Young-Ae Lee, Max Delbrück Center for Molecular Medicine Berlin-Buch, Berlin, Germany email: yolee@mdc-berlin.de Elizabeth S. Eaton Max Delbrueck Center for Molecular Medicine Berlin-Buch University...

...allergies and breast cancer. In a paper published in Nature Communications , researchers at the Max Delbrueck Center for Molecular Medicine Berlin-Buch...
...by Cancer Council Victoria identified 10 new loci variants for estrogen receptor-negative breast cancer. Elizabeth S. Eaton Max Delbrueck Center for Molecular Medicine Berlin-Buch University...

...weight and energy homeostasis by neuronal cell adhesion molecule 1." Nature Neuroscience (2017) Winnie Pong, Staff Writer Max Delbrueck Center for Molecular Medicine Berlin-Buch Cell...

...2017 doi:10.1038/nn.4590 CONTACT: Matthew Poy, Max Delbrück Center for Molecular Medicine, Berlin, Germany email: matthew.poy@mdc-berlin.de Winnie Pong Max Delbrueck Center for Molecular Medicine Berlin-Buch Cell...

...Center for Molecular Medicine Berlin-Buch , Berlin, Germany Wilex AG (Xetra:WL6), Munich, Germany Business: Cancer Alicia Parker HDP-101 Max Delbrueck Center for Molecular Medicine Berlin-Buch Wilex...

...email: k.poole@unsw.edu.au CONTACT: Gary R. Lewin, same affiliation as above email: glewin@mdc-berlin.de Hongjiang Li Lead Discovery Center GmbH Max Delbrueck Center for Molecular Medicine Berlin-Buch Piezo-type...

...myeloma (MM). Wilex declined to disclose financial terms, and MDC did not respond to inquiries. Max Delbrueck Center for Molecular Medicine Berlin-Buch...

...autoimmune disease. The partners declined to provide further details. Formula Pharmaceuticals Inc. , Berwyn, Pa. Max Delbrueck Center for Molecular Medicine Berlin-Buch...

...K. et al. Cancer Discov.; published online Sept. 24, 2014; doi:10.1158/2159-8290.CD-14-0096 Contact: Uta E. Höpken, Max Delbrueck Center for Molecular Medicine...